Literature DB >> 8744521

CT manifestations of pulmonary aspergillosis.

P M Logan1, N L Müller.   

Abstract

The clinical and radiologic manifestations of pulmonary aspergillosis depend on the underlying status of the patients' lung parenchyma and the patients' immunologic response to the infecting agent, most commonly Aspergillus fumigatus. Thus, many different manifestations of pulmonary aspergillosis have been described, with distinct clinical, pathological, and radiological characteristics. Aspergillomas (mycetomas) result from Aspergillus colonization of preexisting lung cavities. Allergic bronchopulmonary aspergillosis results from a hypersensitivity reaction to the fungus in asthmatic patients. Invasive aspergillosis occurs in immunocompromised patients and can take one of many forms, depending on the degree and etiology of the patients' immunosuppression. CT is currently the best imaging modality for the assessment of pulmonary parenchymal disease. In the correct clinical setting, the CT findings frequently suggest a specific diagnosis. The aim of this review is to discuss and illustrate the various CT manifestations of pulmonary aspergillus infection.

Entities:  

Mesh:

Year:  1996        PMID: 8744521

Source DB:  PubMed          Journal:  Crit Rev Diagn Imaging        ISSN: 1040-8371


  5 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 2.  Imaging evaluation of hemoptysis in children.

Authors:  Divya Singh; Ashu Seith Bhalla; Prasad Thotton Veedu; Arundeep Arora
Journal:  World J Clin Pediatr       Date:  2013-11-08

3.  Pulmonary Aspergilloma in Rheumatoid Arthritis.

Authors:  Hariqbal Singh; Piyush Joshi; Vikram Khanna; S G Gupta; S Arora; Vinay Maurya
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 5.  [Pneumonia in immunosuppressed patients].

Authors:  O Solyanik; T Gaass; K Hellbach; J Dinkel
Journal:  Radiologe       Date:  2017-01       Impact factor: 0.635

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.